MedPath

Microneedling plus topical 5-FU in treatment of Vitiligo

Phase 3
Recruiting
Conditions
Vitiligo.
Vitiligo
Registration Number
IRCT20200506047320N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

All patients with stable vitiligo

Exclusion Criteria

Pregnancy and lactation
Age under 10 y
Lesions on face, genitalia and intertriginous areas
Active Koebner phenomenon
Coagulopathy
Active infection
Previous history of keloid or high risk for keloid
Drug hypersensitivity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Repigmentation level in Vitiligo lesions. Timepoint: At beggining of study and then after treatmen starts every 2 weeks for 3 months. Method of measurement: Based on the percentage of repigmentation and classification as 0 to 25 percent, 25 to 50, 50 to 75 and above 75 percent.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath